Journal of Movement Disorders

Papers
(The TQCC of Journal of Movement Disorders is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care64
Update on Current Technologies for Deep Brain Stimulation in Parkinson’s Disease59
Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms37
Emerging Concepts of Motor Reserve in Parkinson’s Disease33
Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers24
Long-Term Outcomes of Genetic Parkinson’s Disease22
Association between Olfactory Deficit and Motor and Cognitive Function in Parkinson’s Disease22
Manganese and Movement Disorders: A Review19
Nutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review17
Telemedicine in an Academic Movement Disorders Center during COVID-1916
Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy14
Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders14
The Non-Motor Symptom Profile of Progressive Supranuclear Palsy14
Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria13
Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy13
Successful Pallidal Stimulation in a Patient with KMT2B-Related Dystonia13
COVID-19 Associated Acute Necrotizing Encephalopathy Presenting as Parkinsonism and Myorhythmia13
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy13
Recurrent ADCY5 Mutation in Mosaic Form with Nocturnal Paroxysmal Dyskinesias and Video Electroencephalography Documentation of Dramatic Response to Caffeine Treatment12
The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease12
Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report11
Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?11
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease11
Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists10
Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease9
Increased Mortality in Young-Onset Parkinson’s Disease9
Management of Parkinson’s Disease in the COVID-19 Pandemic and Future Perspectives in the Era of Vaccination9
Environmental Risk Factors for Progressive Supranuclear Palsy9
Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey9
The Supplementary Motor Complex in Parkinson’s Disease9
Subjective Cognitive Complaints in Cognitively Normal Patients With Parkinson’s Disease: A Systematic Review8
Myoclonus-Ataxia Syndrome Associated with COVID-198
Long-term Effects of Bilateral Subthalamic Deep Brain Stimulation on Postural Instability and Gait Difficulty in Patients with Parkinson’s Disease8
Risk Factors for Falls in Patients with de novo Parkinson’s Disease: A Focus on Motor and Non-Motor Symptoms7
Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene7
Task-Specific Dystonia in a Professional Billiard Player6
Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present6
Potential Link Between Cognition and Motor Reserve in Patients With Parkinson’s Disease6
Potential Benefits and Perils of Incorporating ChatGPT to the Movement Disorders Clinic5
TNR Gene Mutation in Familial Parkinson’s Disease: Possible Implications for Essential Tremor5
The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson’s Disease: A Korean Mendelian Randomization Study5
The Four Square Step Test for Assessing Cognitively Demanding Dynamic Balance in Parkinson’s Disease Patients5
Umami and Other Taste Perceptions in Patients With Parkinson’s Disease5
Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for Parkinson’s Disease: Observations from a Single Indian Center5
Labrune’s Syndrome Presenting With Stereotypy-Like Movements and Psychosis: A Case Report and Review5
Minipolymyoclonus: A Critical Appraisal5
Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis5
Automatic Measurement of Postural Abnormalities With a Pose Estimation Algorithm in Parkinson’s Disease4
Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia4
Focused Vibrotactile Stimulation with Cueing Effect on Freezing of Gait in Parkinson’s Disease: Two Case Reports4
Factors Associated with Medication Beliefs in Patients with Parkinson’s Disease: A Cross-Sectional Study4
Clinical and Imaging Profile of Patients with Joubert Syndrome4
Future of Tanscranial Magnetic Stimulation in Movement Disorders: Introduction of Novel Methods4
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale4
Sedentary Time is Associated with Worse Attention in Parkinson’s Disease: A Pilot Study4
Dopa-Responsive Dystonia: A Male Patient Inherited a Novel GCH1 Deletion from an Asymptomatic Mother4
Long-Term Outcome of Hemimasticatory Spasm3
Bupropion-Induced Dystonia in a Patient with Parkinson’s Disease3
A Rare Case of Late Adult-Onset Niemann-Pick Disease Type C3
Treatable Ataxias: How to Find the Needle in the Haystack?3
Content Analysis of Korean Videos Regarding Restless Legs Syndrome on YouTube3
Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease3
The Case of a Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting with a Prolonged History of Stuttering Speech and a Misdiagnosis of Parkinson’s Disease3
Young-Onset Parkinson’s Disease with Impulse Control Disorder Due to Novel Variants of F-Box Only Protein 73
Changes in Cerebral Gray and White Matter in Patients with Pantothenate Kinase-Associated Neurodegeneration: A Long-Term Magnetic Resonance Imaging Follow-Up Study3
Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis3
Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm3
GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy3
Constipation is Associated With Mild Cognitive Impairment in Patients With de novo Parkinson’s Disease3
Treatment of Acute Delirium in a Patient with Parkinson’s Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine3
A KMT2B Frameshift Variant Causing Focal Dystonia Restricted to the Oromandibular Region After Long-Term Follow-up3
0.018539905548096